Advertisement
CMS and FDA advocate for device identifiers on claims forms

CMS and FDA advocate for device identifiers on claims forms

By Adam Rubenfire  |  July 14, 2016

The heads of the CMS and the Food and Drug Administration want universal health insurance claims forms to include unique device identifiers. The UDI would improve post-market surveillance and provide for better value-based reimbursement based on device performance, they say.

The PBM value-price equation

By Howard Wolinsky  |  June 11, 2016

Are the drugs excluded from formularies by pharmacy benefits managers really no better than what's available at a cheaper price?

What a Fitbit or a tweet can tell drugmakers about their products

What a Fitbit or a tweet can tell drugmakers about their products

By Beth Kutscher  |  June 08, 2016

Health systems and hospitals that are taking financial risk for keeping people healthy aren't the only ones that want access to patient-generated data. Drug and biotech firms know patient-reported information can help get their products to market faster and assess how they perform in the real world.

Tapping new dimensions: the promise of 3-D printing

Tapping new dimensions: the promise of 3-D printing

By Adam Rubenfire  |  May 21, 2016

Physicians have increasingly looked to 3-D printing for unique implants and surgical models, and some manufacturers are now using the method to mass produce medical devices and even drugs that are more precise, customizable and biocompatible than conventionally produced products.

FDA says biosimilars should use reference drug label data

By Adam Rubenfire  |  April 02, 2016

The Food and Drug Administration is recommending that biosimilar labels carry the clinical data gathered by the product the biosimilar is intended to emulate. Biosimilars are derived from living organisms, and therefore may not be identical to brand-name drugs.

Blog: The well-sung Diabetes Prevention Program

By Merrill Goozner  |  March 30, 2016

The CMS' decision this week to pay for the Diabetes Prevention Program is long overdue since its success in reducing obesity and thereby diabetes risk has been well documented in the medical and healthcare economics literature, and covered by certain sections of the press—like us.

Providers must practice patience in labor and delivery

By Modern Healthcare  |  March 19, 2016

I read with interest the article “In California, where moms deliver affects whether they have a C-section." As a private-practice OB-GYN for the past 23 years working mostly in a community hospital, the numbers showing high variability in the state certainly raise the question, who is...

The hard work ahead on adopting uniform quality measures

The hard work ahead on adopting uniform quality measures

By Melanie Evans  |  February 20, 2016

For more than a year, top officials from Medicare, the nation's largest health plans, medical societies and major employers and consumer groups hammered away at a dreadful task: getting everyone to agree to use identical quality measures for the treatment of heart disease, cancer and other common...

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print